Kiora Pharmaceuticals, Inc.
KPRX
$2.50
-$0.08-3.10%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.09M | 19.38M | 20.67M | 24.11M | 26.79M |
| Total Receivables | 3.32M | 2.67M | 3.11M | 2.06M | 871.40K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.34M | 650.40K | 957.10K | 941.50K | 2.04M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 21.75M | 22.69M | 24.74M | 27.11M | 29.71M |
|
|
|||||
| Total Current Assets | 21.75M | 22.69M | 24.74M | 27.11M | 29.71M |
| Net Property, Plant & Equipment | 377.50K | 419.80K | 455.90K | 157.10K | 62.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | 0.00 |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.13M | 6.75M | 6.75M | 6.76M | 6.72M |
| Total Assets | 24.25M | 29.86M | 31.95M | 34.02M | 36.48M |
|
|
|||||
| Total Accounts Payable | 1.06M | 241.50K | 282.50K | 942.50K | 415.60K |
| Total Accrued Expenses | 2.26M | 2.15M | 1.62M | 1.07M | 2.26M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 164.50K | 155.90K | 143.30K | 71.60K | 23.40K |
| Total Finance Division Other Current Liabilities | 142.10K | 29.10K | 1.14M | 3.20M | 3.31M |
| Total Other Current Liabilities | 142.10K | 29.10K | 1.14M | 3.20M | 3.31M |
| Total Current Liabilities | 3.63M | 2.58M | 3.19M | 5.27M | 6.01M |
|
|
|||||
| Total Current Liabilities | 3.63M | 2.58M | 3.19M | 5.27M | 6.01M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 203.80K | 248.20K | 287.10K | 87.50K | 33.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.29M | 4.62M | 6.35M | 4.96M | 4.68M |
| Total Liabilities | 8.13M | 7.45M | 9.82M | 10.32M | 10.72M |
|
|
|||||
| Common Stock & APIC | 170.59M | 170.36M | 170.10M | 169.57M | 169.42M |
| Retained Earnings | -154.22M | -147.70M | -147.73M | -145.58M | -143.38M |
| Treasury Stock & Other | -246.10K | -243.70K | -245.80K | -297.20K | -282.20K |
| Total Common Equity | 16.13M | 22.41M | 22.13M | 23.70M | 25.76M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
|
|||||
| Total Common Equity | 16.13M | 22.41M | 22.13M | 23.70M | 25.76M |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 16.13M | 22.41M | 22.13M | 23.70M | 25.76M |
|
|
|||||